FDA Approved: JADENU — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved Jadenu (deferasirox) from Novartis as an oral iron chelator for chronic iron overload due to blood transfusions. This is the original applicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload

Drugs mentioned

• JADENU (deferasirox)

Snippet

ORIG AP for JADENU (DEFERASIROX)